Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Thymoma × Paclitaxel × Clear all

Phase

Status

Sponsor Class

NETWORK 2 OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 7 Breast Neoplasms 5 Stomach Neoplasms 4 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymoma 1 Small Cell Lung Carcinoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1 Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 1 olaparib 1 lenvatinib 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05832827 2023-10-23

Artemis

National Cancer Center, Japan

Phase 2 Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡